APOTHEEK FRANSEN
ActiveAPOTHEEK FRANSEN has been active since 1987 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €887k and a net result of €176k. Equity is growing by ~25.4% per year across the filed fiscal years. Its solvency ranks better than 92% of 10242 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
100
/ 100
Excellent▲ +17 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability99▲+6
Solvency100=
Growth78=
Stability100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €90k at 30 days acceptable
Liquidity ample (current ratio 6.85 against 7.39 in 2024), and 14.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
85.4%
Return on assets
16.9%
Age of the figures
8 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
1 d early
2024
2 d early
2023
22 d early
2022
5 d early
2021
19 d early
2020
116 d early
2019
64 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€887k▲ 5.2%
2024 · €843k
2018: €214k
2019: €270k
2020: €366k
2022: €532k
2023: €686k
2024: €843k
2018 → 2025
Total assets
€1.04M▼ 7.1%
2024 · €1.12M
2018: €480k
2019: €414k
2020: €442k
2022: €822k
2023: €949k
2024: €1.12M
2018 → 2025
Net result
€176k▲ 12.1%
2024 · €157k
2018: €101k
2019: €121k
2020: €96k
2022: €123k
2023: €154k
2024: €157k
2018 → 2025
Working capital
€873k▼ 7.7%
2024 · €946k
2018: €186k
2019: €241k
2020: €338k
2022: €664k
2023: €797k
2024: €946k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202022202320242025Trend
Equity€366k-€532k▲ 45.5%€686k▲ 29.0%€843k▲ 22.9%€887k▲ 5.2%
Operating result€130k-€211k▲ 62.0%€183k▼ 13.0%€216k▲ 18.0%€222k▲ 2.5%
Net result€96k-€123k▲ 27.6%€154k▲ 25.8%€157k▲ 1.7%€176k▲ 12.1%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 3% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.04M
Fixed assets
€16k▼ 29.1%
Current assets
€1.02M▼ 6.6%
Equity and liabilities €1.04M
Equity
€887k▲ 5.2%
Debt
€152k▼ 44.8%
The debt ratio falls from 24.5% to 14.6%: equity grows while debt is paid down.
Key figures and ratios
EBITDA
€228k▲
2024 · €222k
Cash flow
€183k▲
2024 · €163k
Solvency
85.4%▲
2024 · 75.5%
Current ratio
6.85▼
2024 · 7.39
Quick ratio
5.65▼
2024 · 6.18
Debt / equity
0.17▼
2024 · 0.33
ROE
19.8%▲
2024 · 18.6%
ROA
16.9%▲
2024 · 14.0%
Interest coverage
105.43▲
2024 · -149.15
Debt
€152k▼
2024 · €274k
Debt ≤ 1 year
€149k▲
2024 · €148k
Debt > 1 year
€0▼
2024 · €125k
Income taxes
€50k▼
2024 · €74k
Staff costs
€155k▼
2024 · €175k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.12M€1.04M▼
Fixed assets21/28€23k€16k▼
Intangible fixed assets21€1k€302▼
Tangible fixed assets22/27€22k€16k▼
Land and buildings22€4k€2k▼
Plant, machinery and equipment23€14k€11k▼
Furniture and vehicles24€4k€3k▼
Financial fixed assets28€70€70=
Current assets29/58€1.09M€1.02M▼
Stocks and contracts in progress3€179k€179k▼
Stocks30/36€179k€179k▼
Amounts receivable within one year40/41€114k€143k▲
Trade receivables40€114k€143k▲
Current investments50/53€480k€509k▲
Cash at bank and in hand54/58€308k€183k▼
Deferred charges and accrued income490/1€13k€8k▼
Equity and liabilities
Total equity and liabilities10/49€1.12M€1.04M▼
Equity10/15€843k€887k▲
Contributions10/11€37k€37k=
Reserves13€804k€848k▲
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Tax-exempt reserves132€129k€187k▲
Distributable reserves133€674k€659k▼
Profit (loss) carried forward14€2k€2k=
Amounts payable17/49€274k€152k▼
Amounts payable after more than one year17€125k€0▼
Financial debts170/4€125k€0▼
Amounts payable within one year42/48€148k€149k▲
Trade debts44€75k€82k▲
Suppliers440/4€75k€82k▲
Taxes, remuneration and social security45€61k€55k▼
Taxes450/3€28k€39k▲
Remuneration and social security454/9€33k€17k▼
Other amounts payable47/48€12k€12k▼
Accrued charges and deferred income492/3€1k€2k▲
Income statement
Code20242025
Remuneration, social security and pensions62€175k€155k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6k€7k▲
Other operating charges640/8€2k€2k▲
Gross operating margin9900€399k€386k▼
Operating profit (loss)9901€216k€222k▲
Financial income75/76B€14k€6k▼
Recurring financial income75€14k€6k▼
Financial charges65/66B€-1k€2k▲
Recurring financial charges65€-1k€2k▲
Profit (loss) for the period before taxes9903€231k€226k▼
Income taxes67/77€74k€50k▼
Profit (loss) for the period9904€157k€176k▲
Transfer from tax-exempt reserves789€72k€0▼
Transfer to tax-exempt reserves689€63k€59k▼
Profit (loss) for the period to be appropriated9905€165k€117k▼
Appropriation of the result
Profit (loss) to be appropriated9906€167k€119k▼
Profit (loss) brought forward from the previous period14P€2k€2k=
Transfer from equity791/2-€132k
Transfer to equity691/2€165k€117k▼
To other reserves6921€165k€117k▼
Profit to be distributed694/7-€132k
Return on contributions (dividend)694-€132k
Social balance
Average headcount (FTE)90872.52.4▼
The notes to these accounts (22 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Highest result since 2018net €176k ▲12.1%
Operating result €222k, net result €176k, both a record.
29-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
09-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
26-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Equity above €500kEq €532k ▲45.5%
4 profitable years in a row build equity to €532k.
12-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
06-04
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial
Weakest financial yearnet €96k ▼20.5%
Net result drops to €96k, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity doublescurrent ratio 5.47
Current ratio from 2.67 to 5.47; short-term debt falls from €144k to €76k.
28-05
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
07-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
13-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
13-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hoogstraten · 1 establishment unit since 1987
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Vrijheid 1602320 HoogstratenGround area
491 m²
Building footprint
290 m²
Volume, LiDAR
2,360 m³
Parcel 13014E0118/00H000, Flanders · tallest building 12.4 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
APOTEEK FRANSEN
since 19872.031.676.084
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13014E0118/00H000 | Flanders | 491 m² | 1 · 290 m² | 12.4 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).
Public money · subsidies and aid
Flemish government
2025 · 1 entry · 84 EUR awarded · 84 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 84 EUR | 84 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Recognitions · licences · registrations
Food safety, FASFC
1 siteHoogstraten2.031.676.084
Similar companies · same sector, comparable size
Apotheek Oude Brug
BE 0658.946.734
Lokeren · Eq €886k
UNIDOSE PHARMA
BE 0467.278.989
Izegem · Eq €889k
EASI
BE 0811.270.485
Ciney · Eq €884k
Vandewalle-Verrue
BE 0831.028.692
Vleteren · Eq €890k
XPHARMA
BE 0663.736.158
Puurs-Sint-Amands · Eq €890k
Of 5,209 companies in sector 47730 we hold annual accounts for 3,851. 3,097 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded11-12-1987
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 38 filingsAddress and cadastre registers
Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.